258 related articles for article (PubMed ID: 26645638)
21. Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats.
Miller LL; Leitl MD; Banks ML; Blough BE; Negus SS
Pain; 2015 Jan; 156(1):175-184. PubMed ID: 25599313
[TBL] [Abstract][Full Text] [Related]
22. Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
Horton DB; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2011 Oct; 339(1):286-97. PubMed ID: 21778282
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
24. Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats.
López-Arnau R; Buenrostro-Jáuregui M; Camarasa J; Pubill D; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):247-254. PubMed ID: 29349706
[TBL] [Abstract][Full Text] [Related]
25. 'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function.
Saha K; Partilla JS; Lehner KR; Seddik A; Stockner T; Holy M; Sandtner W; Ecker GF; Sitte HH; Baumann MH
Neuropsychopharmacology; 2015 May; 40(6):1321-31. PubMed ID: 25502630
[TBL] [Abstract][Full Text] [Related]
26. Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.
Suyama JA; Banks ML; Negus SS
Psychopharmacology (Berl); 2019 Mar; 236(3):1057-1066. PubMed ID: 30232529
[TBL] [Abstract][Full Text] [Related]
27. Differences in dopamine responsiveness to drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer 344 rats.
Cadoni C; Di Chiara G
J Neurochem; 2007 Oct; 103(2):487-99. PubMed ID: 17666048
[TBL] [Abstract][Full Text] [Related]
28. In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat.
Baumann MH; Clark RD; Woolverton WL; Wee S; Blough BE; Rothman RB
J Pharmacol Exp Ther; 2011 Apr; 337(1):218-25. PubMed ID: 21228061
[TBL] [Abstract][Full Text] [Related]
29. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
Heidbreder C; Feldon J
Synapse; 1998 Aug; 29(4):310-22. PubMed ID: 9661249
[TBL] [Abstract][Full Text] [Related]
30. Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens.
Andrews CM; Lucki I
Psychopharmacology (Berl); 2001 May; 155(3):221-9. PubMed ID: 11432683
[TBL] [Abstract][Full Text] [Related]
31. Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.
Bauer CT; Banks ML; Blough BE; Negus SS
Br J Pharmacol; 2013 Feb; 168(4):850-62. PubMed ID: 22978626
[TBL] [Abstract][Full Text] [Related]
32. Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats.
Hutsell BA; Baumann MH; Partilla JS; Banks ML; Vekariya R; Glennon RA; Negus SS
Eur Neuropsychopharmacol; 2016 Feb; 26(2):288-297. PubMed ID: 26738428
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of N-ethylpentylone and its effect on increasing levels of dopamine and serotonin in the nucleus accumbens of conscious rats.
Lin Z; Chen Y; Li J; Xu Z; Wang H; Lin J; Ye X; Zhao Z; Shen Y; Zhang Y; Zheng S; Rao Y
Addict Biol; 2020 May; 25(3):e12755. PubMed ID: 30985062
[TBL] [Abstract][Full Text] [Related]
34. 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats.
Borycz J; Zapata A; Quiroz C; Volkow ND; Ferré S
Neuropsychopharmacology; 2008 Feb; 33(3):619-26. PubMed ID: 17487226
[TBL] [Abstract][Full Text] [Related]
35. Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.
Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
Neuropharmacology; 2018 May; 134(Pt A):46-56. PubMed ID: 28851615
[TBL] [Abstract][Full Text] [Related]
36. Serotonin-2C antagonism augments the effect of citalopram on serotonin and dopamine levels in the ventral tegmental area and nucleus accumbens.
Visser AK; Kleijn J; van Faassen MH; Dremencov E; Flik G; Kema IP; Den Boer JA; van Waarde A; Dierckx RA; Bosker FJ
Neurochem Int; 2015 Feb; 81():10-5. PubMed ID: 25542858
[TBL] [Abstract][Full Text] [Related]
37. Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.
Baumann MH; Ayestas MA; Dersch CM; Partilla JS; Rothman RB
Ann N Y Acad Sci; 2000 Sep; 914():172-86. PubMed ID: 11085319
[TBL] [Abstract][Full Text] [Related]
38. Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.
Rothman RB; Katsnelson M; Vu N; Partilla JS; Dersch CM; Blough BE; Baumann MH
Eur J Pharmacol; 2002 Jun; 447(1):51-7. PubMed ID: 12106802
[TBL] [Abstract][Full Text] [Related]
39. Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Kurling S; Kankaanpää A; Seppälä T
Behav Brain Res; 2008 May; 189(1):191-201. PubMed ID: 18261810
[TBL] [Abstract][Full Text] [Related]
40. Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α
Jiang JL; El Mansari M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109987. PubMed ID: 32474007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
